top of page

Announcing the Launch of Occuity's New Investment Round

  • Writer: Dr. Dan Daly
    Dr. Dan Daly
  • Jul 24
  • 2 min read

Updated: Jul 25

Join Us on Our Mission to Transform Healthcare Through the Eye


At Occuity, we believe that the eye is more than a window to the soul — it’s a window to your health.


As pioneers in the emerging field of Oculomics, we’re developing ground-breaking, handheld, non-invasive devices that use light to scan the eye — enabling early detection and monitoring of chronic diseases like myopia, diabetes, and Alzheimer’s.


Following a year of major progress — including the launch of our first revenue-generating product, the PM1 Pachymeter, the expansion of our global distribution network, and significant technical advances across our roadmap — we're excited to announce the launch of Occuity’s new investment round.


Why Now?


The opportunity is immense and the timing is critical.


Our next device — the AX1 Axiometer™ — is just months away from launch and is already attracting strong demand from distributors, clinicians and global myopia management providers. It represents a game-changing solution for the fast-growing myopia management market and is forecast to deliver rapid, scalable revenues.



This funding round will accelerate the AX1’s commercial rollout, scale manufacturing, and support the continued development of our optical platform — the foundation for our future Oculomics-based screening devices.


Why Invest?


  • Proven Technology – 15 patents and working commercial devices

  • First Revenues Achieved – PM1 CE Marked, launched and generating income through global network of 18 distributors

  • Clear Product Roadmap – AX1 is close to market and represents a much larger opportunity

  • Scalable Platform – A unique optical system core to our future applications in early disease detection

  • Global Impact Potential – Improving lives for people throughout the world while addressing multi-billion dollar markets


This is a unique opportunity to support a bold British medtech company with the potential to reshape preventative healthcare.


How to Invest


You can invest in Occuity in two ways:


  • Direct investment – For interested investors who can self-certify as HNWI /Sophisticated Investors AND are making investments of over £10k. Click here to learn more.

  • Via Crowdcube - For those who wish to invest but do not fit the criteria for direct investment investment, we will also be running a public campaign on Crowdcube. (Launch date TBC – expected late August)


Webinars


We’ll be hosting two live webinars:


  • 📅 31st July at 10:00 - aimed at existing shareholders - REGISTER NOW

  • 📅 18th August at 14:00 - aimed at new investors 


Register now to secure your place and hear directly from the Occuity leadership team.



Ready to Join Us?


You can read our Executive Summary here.



A full Investment Memorandum and accompanying Appendix and Technical Document are available for those who can self-certify as a HNW or sophisticated investor.



Let’s build the future of preventative healthcare — together.

Comments


bottom of page